Quantum-Si to Participate in the H.C. Wainwright 26th Annual Global Investment Conference
Quantum-Si (Nasdaq: QSI), known as The Protein Sequencing Company™, has announced its participation in the 26th Annual H.C. Wainwright Global Investment Conference. The event is scheduled to take place in New York City from September 9-11, 2024.
CEO Jeff Hawkins will be featured in a fireside chat on Tuesday, September 10th, at 4:00 PM ET. Investors and interested parties can access a live and archived webcast of the event through the 'Investors' section of Quantum-Si's website, under the Events & Presentations tab.
This participation highlights Quantum-Si's engagement with the investment community and provides an opportunity for the company to showcase its developments in protein sequencing technology to a global audience.
Quantum-Si (Nasdaq: QSI), conosciuta come The Protein Sequencing Company™, ha annunciato la propria partecipazione alla 26ª Conferenza Globale di Investimento Annuale H.C. Wainwright. L'evento si svolgerà a New York City dal 9 all'11 settembre 2024.
Il CEO Jeff Hawkins parteciperà a una discussione informale martedì 10 settembre alle 16:00 ET. Gli investitori e gli interessati possono accedere a un webcast dal vivo e registrato dell'evento attraverso la sezione 'Investitori' del sito web di Quantum-Si, nella scheda Eventi e Presentazioni.
Questa partecipazione sottolinea l'impegno di Quantum-Si con la comunità degli investitori e offre l'opportunità all'azienda di presentare i propri progressi nella tecnologia di sequenziamento delle proteine a un pubblico globale.
Quantum-Si (Nasdaq: QSI), conocida como The Protein Sequencing Company™, ha anunciado su participación en la 26ª Conferencia Anual Global de Inversión H.C. Wainwright. El evento está programado para llevarse a cabo en New York City del 9 al 11 de septiembre de 2024.
El CEO Jeff Hawkins estará presente en una charla informal el martes 10 de septiembre a las 4:00 PM ET. Los inversores y partes interesadas pueden acceder a un webcast en vivo y grabado del evento a través de la sección 'Inversores' en el sitio web de Quantum-Si, bajo la pestaña Eventos y Presentaciones.
Esta participación destaca el compromiso de Quantum-Si con la comunidad inversora y proporciona una oportunidad para que la empresa muestre sus avances en tecnología de secuenciación de proteínas a una audiencia global.
Quantum-Si (Nasdaq: QSI), 단백질 서열 결정 회사™로 알려진, 제26회 H.C. Wainwright 글로벌 투자 컨퍼런스에 참가한다고 발표했습니다. 이 행사는 2024년 9월 9일부터 11일까지 뉴욕시에서 개최됩니다.
CEO Jeff Hawkins는 9월 10일 화요일 오후 4시 ET에 진행되는 대화에 참여할 예정이며, 투자자와 관심 있는 분들은 Quantum-Si의 웹사이트 '투자자' 섹션의 이벤트 및 프레젠테이션 탭을 통해 라이브 및 녹화된 웹캐스트에 접근할 수 있습니다.
이번 참가로 Quantum-Si는 투자 커뮤니티와의 관계를 강조하고, 단백질 서열 결정 기술의 발전을 글로벌 청중에게 선보일 기회를 제공합니다.
Quantum-Si (Nasdaq: QSI), connue sous le nom de The Protein Sequencing Company™, a annoncé sa participation à la 26e Conférence Annuelle Globale d'Investissement H.C. Wainwright. L'événement est prévu pour se dérouler à New York City du 9 au 11 septembre 2024.
Le PDG Jeff Hawkins participera à une discussion informelle le mardi 10 septembre à 16h00 ET. Les investisseurs et parties intéressées peuvent accéder à un webinaire en direct et enregistré de l'événement via la section 'Investisseurs' du site web de Quantum-Si, sous l'onglet Événements et Présentations.
Cette participation souligne l'engagement de Quantum-Si envers la communauté d'investissement et offre à l'entreprise l'occasion de présenter ses avancées dans la technologie de séquençage des protéines à un public mondial.
Quantum-Si (Nasdaq: QSI), bekannt als The Protein Sequencing Company™, hat seine Teilnahme an der 26. jährlichen H.C. Wainwright Global Investment Conference angekündigt. Die Veranstaltung findet von 9. bis 11. September 2024 in New York City statt.
CEO Jeff Hawkins wird am Dienstag, den 10. September um 16:00 Uhr ET an einer informellen Diskussion teilnehmen. Investoren und Interessierte können über den Bereich 'Investoren' der Quantum-Si-Website unter dem Tab Veranstaltungen & Präsentationen auf einen live und archivierten Webcast der Veranstaltung zugreifen.
Diese Teilnahme hebt das Engagement von Quantum-Si in der Investmentgemeinschaft hervor und bietet dem Unternehmen die Gelegenheit, seine Entwicklungen in der Prote Sequenzierungstechnologie einem globalen Publikum vorzustellen.
- None.
- None.
Jeff Hawkins, Quantum-Si's Chief Executive Officer, will participate in a fireside chat on Tuesday, September 10th, at 4:00 PM ET.
A live and archived webcast of the event will be available in the “Investors” section of the Quantum-Si website under Events & Presentations.
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on revolutionizing the growing field of proteomics. The Company's suite of technologies is powered by a first-of-its-kind semiconductor chip designed to enable next-generation single-molecule protein sequencing and digitize proteomic research in order to advance drug discovery and diagnostics beyond what has been possible with DNA sequencing. Learn more at quantum-si.com or follow us on LinkedIn or X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240826297214/en/
Investor Contact
Doug Farrell, VP, Investor Relations
ir@quantum-si.com
Media Contact
Katherine Atkinson, SVP of Commercial Marketing
media@quantum-si.com
Source: Quantum-Si Incorporated
FAQ
When is Quantum-Si (QSI) participating in the H.C. Wainwright Global Investment Conference?
What is the date and time of Jeff Hawkins' fireside chat at the H.C. Wainwright conference?
How can investors access the webcast of Quantum-Si's (QSI) presentation at the H.C. Wainwright conference?
What is Quantum-Si's (QSI) primary focus as a company?
